Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors
Go back to Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors| DaVita Inc. (NYSE: DVA) | Delayed: 183.86 +0.77 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $183.09 | 52 Week High | $78.77 | |||
| Open | $183.96 | 52 Week Low | $55.00 | |||
| Day High | $185.85 | P/E | 63.62 | |||
| Day Low | $181.27 | EPS | $2.89 | |||
| Volume | 2,098,920 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.89 -0.25 (6.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.14 | 52 Week High | $45.34 | |||
| Open | $4.15 | 52 Week Low | $15.92 | |||
| Day High | $4.17 | P/E | 1.67 | |||
| Day Low | $3.86 | EPS | $2.33 | |||
| Volume | 3,509,964 | |||||
